Ameristem

Biotechnology ResearchUnited States11-50 Employees

Ameristem... Celebrating the power of life. 

Ameristem proprietary technology enables recovery of the most potent stem cells from dental pulp - Immature Dental Pulp Stem Cells (IDPSC). Stem Cell therapy is destined to become an important part of medicine in the near future. 

Immature Dental Pulp Stem Cells were discovered in 2004 by Ameristem's founders Dr. Alexander Kerkis and Dr. Irina Kerkis .

In animal experiments, Immature Dental Pulp Stem Cells, have been found to contribute to virtually every tissue. 

IDPSC are unmatched in the speed of prolifiration, ease of harvesting and handling, and their ability to repair damaged tissues. 

Immature Dental Pulp Stem Cells can only be harvested using a proprietary technology - dental pulp organ culture - developed by Ameristem founders. 

Even if you have already preserved your child's cord blood, preserving IDPSC's is greatly recommended due to the possible benefits they offer over cord blood cells.

Sign up for free to view info

Email Format Employee directory